Our work also tested the role of GRP78, a well-characterized survival component of the UPR [28] that is upregulated and promotes drug resistance of quiescent squamous cell carcinoma (HNSCC) cells [17]. The gene discussed is HSPA5; the disease is squamous cell carcinoma.